Ignite Creation Date:
2024-05-06 @ 1:54 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04153422
Status:
RECRUITING
Last Update Posted:
2024-06-13
First Post:
2019-11-04
Brief Title:
IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS FGFR-3 or Plexin D1 Antibodies
Sponsor:
Henry Ford Health System
Organization:
Henry Ford Health System
Organization Data
Organization:
Henry Ford Health System
Class:
OTHER
Study ID:
212029
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Henry Ford Health System
Lead Sponsor Class:
OTHER
Responsible Party:
Lawrence Zeidman MD FAAN
Responsible Party Title:
Senior Staff Neuromuscular Division Henry Ford Hospital Associate Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Henry Ford Health System
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Octapharma USA Inc | UNKNOWN |